1403864-98-1

Basic information

• Product Name: (1R,2R,5R)-5-amino-2-methylcyclohexan-1-ol hydrochloride
• Synonyms: (1R,2R,5R)-5-amino-2-methylcyclohexan-1-ol hydrochloride
• CAS NO: 1403864-98-1
• Molecular Weight: 165.663
• Mol File: 1403864-98-1.mol

Chemical Properties

• CAS DataBase Reference: (1R,2R,5R)-5-amino-2-methylcyclohexan-1-ol hydrochloride(CAS DataBase Reference)
• NIST Chemistry Reference: (1R,2R,5R)-5-amino-2-methylcyclohexan-1-ol hydrochloride(1403864-98-1)
• EPA Substance Registry System: (1R,2R,5R)-5-amino-2-methylcyclohexan-1-ol hydrochloride(1403864-98-1)

Safety Data

• Hazardous Substances Data: 1403864-98-1(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
(1R,2R,5R)-5-amino-2-methylcyclohexan-1-ol hydrochloride is used as a chiral building block for the synthesis of various pharmaceutical compounds, contributing to the development of new drugs with improved efficacy and selectivity.
Used in Agrochemical Industry:
(1R,2R,5R)-5-amino-2-methylcyclohexan-1-ol hydrochloride is used as a chiral building block for the synthesis of agrochemical compounds, potentially enhancing the performance and selectivity of these products in agricultural applications.
Used in Research and Development:
(1R,2R,5R)-5-amino-2-methylcyclohexan-1-ol hydrochloride is used in research and development for medicinal purposes, exploring its biological activity and potential applications in drug discovery and design.

Upstream product

• 121424-36-0 (+)-(1R)-4-methyl-cyclohex-3-enecarboxylic acid 
• 141484-09-5 (+)-(1R)-4-methyl-3-cyclohexenamine 
• 141484-07-3 (-)-(1S)-4-methyl-3-cyclohexen-1-yl 4-methylbenzenesulfonate 
• 78-79-5 isoprene 
• 1403864-94-7 tert-butyl ((1R,3R,4R)-3-hydroxy-4-methylcyclohexyl)carbamate 

Downstream Products

• 1403859-14-2 2-(tert-butylamino)-4-{[(1R,3R,4R)-3-hydroxy-4-methylcyclohexyl]amino}pyrimidine-5-carboxamide 
• 1403865-34-8 4-((3R,4R)-3-hydroxy-4-methylcyclohexylamino)-2-(1-methylcyclopropylamino)pyrimidine-5-carbonitrile 
• 1403864-81-2 4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-2-(methylthio)pyrimidine-5-carbonitrile 

Relevant articles and documents

METHODS OF SYNTHESIS OF (1R,2R,5R)-5-AMINO-2-METHYLCYCLOHEXANOL HYDROCHLORIDE AND INTERMEDIATES USEFUL THEREIN

Provided herein are methods and intermediates for making (lR,2R,5R)-5-amino-2- methylcyclohexanol hydrochloride, which are useful for the preparation of compounds useful for the treatment of a disease, disorder, or condition associated with the JNK pathwa

SOLID FORMS OF 2-(TERT-BUTYLAMINO)-4-((1R,3R,4R)-3-HYDROXY-4-METHYLCYCLOHEXYLAMINO)-PYRIMIDINE-5-CARBOXAMIDE, COMPOSITIONS THEREOF AND METHODS OF THEIR USE

Provided herein are formulations, processes, solid forms and methods of use relating to 2-(tert-butylamino)-4-((1R,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5-carboxamide.

SOLID FORMS OF 2-(TERT-BUTYLAMINO)-4-((1R,3R,4R)-3-HYDROXY-4-METHYLCYCLOHEXYLAMINO)-PYRIMIDINE-5-CARBOXAMIDE, COMPOSITIONS THEREOF AND METHODS OF THEIR USE

Provided herein are formulations, processes, solid forms and methods of use relating to 2- (tert-butylamino)-4-((lR,3R,4R)-3-hydroxy-4-methylcyclohexylamino)-pyrimidine-5- carboxamide.

SUBSTITUTED DIAMINOCARBOXAMIDE AND DIAMINOCARBONITRILE PYRIMIDINES, COMPOSITIONS THEREOF, AND METHODS OF TREATMENT THEREWITH

Provided herein are Diaminopyrimidine Compounds having the following structures: wherein R1, R2, R3, and R4 are as defined herein, compositions comprising an effective amount of a Diaminopyrimidine Compound, and methods for treating or preventing liver fibrotic disorders or a condition treatable or preventable by inhibition of a JNK pathway.